Soc. Generale Call 42 FRE 20.06.2.../ DE000SW1ESZ0 /
14/05/2024 13:06:41 | Diferencia0.000 | Bid13:47:25 | Ask13:47:25 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.049EUR | 0.00% | 0.049 Volumen de oferta: 125,000 |
0.059 Tamaño/ Volumen/ Formato de Ask: 125,000 |
FRESENIUS SE+CO.KGAA... | 42.00 - | 20/06/2025 | Call |
GlobeNewswire
13:45
Global Technologies, Ltd. Announces Its Financial Results for the Quarter Ended March 31, 2024 and t...
Newsfile Corp
13:44
Appia Announces Encouraging Initial Results from the Newly Identified Taygeta and Merope Exploration...
GlobeNewswire
13:30
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire
13:30
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire
13:30
ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire
13:30
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire
13:30
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
13:30
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
13:30
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
13:30
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
13:30
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire
13:30
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire
13:30
Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página